Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuromedin B receptor (NMBR), also known as BB1, is a G protein-coupled receptor (GPCR) with seven transmembrane domains. Its endogenous ligand is neuromedin B. NMBR mediates various physiological functions by binding neuromedin B, which acts as a potent mitogen and growth factor for normal and neoplastic lung tissue and gastrointestinal epithelial cells. Antagonists targeting NMBR may have therapeutic potential for inhibiting tumor cell growth. Polymorphisms in the NMBR gene have been associated with susceptibility to schizophrenia.
Antagonists targeting NMBR may inhibit tumor cell growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuromedin B Receptor (NMBR).